"This year has been an extremely successful year for LENZ, and we have continued to make progress in the fourth quarter and ...

New Drug Application (NDA) for LNZ100 for treatment of presbyopia on track for PDUFA target action date of August 8, 2025 Upon FDA approval, commercial launch activities to commence immediately with ...